Gina R. Shockley


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.


Gina Shockley counsels biotechnology and pharmaceutical manufacturers, pharmacy and pharmaceutical distribution companies, managed care organizations, pharmacy benefit managers (PBMs), group purchasing organizations, clinical trial and research organizations, and health information technology businesses on all aspects of contracting, regulatory and operational matters.

Drawing on her years of experience within the pharmacy benefit manager (PBM) and pharmaceutical industry, Gina is able to combine legal guidance with practical business counsel to help companies achieve their business objectives. Gina’s practice includes:

  • Pharmaceutical Supply Chain – Advising companies of all sizes on complex strategic projects; negotiating large transactions to ensure compliance with healthcare related laws, including the Anti-Kickback Statute, the False Claims Act (FCA), and the Civil Monetary Penalty Act.
  • Drug Distribution – Providing strategic and contracting support to supply chain participants including pharmacies, manufacturers and PBMs.
  • Regulatory Guidance – Counseling on issues relating to managed care, product liability implications, HIPAA, OIG guidance, fraud and abuse, Foreign Corrupt Practices Act (FCPA), FCA, PhRMA Code, federal and state reporting obligations, and Lanham Act/unfair competition.

Prior to joining Bass, Berry & Sims, Gina served as Vice President & Associate General Counsel, Supply Chain at Express Scripts, Inc. where she managed the legal support of the supply chain operations for the company across the United States, Canada and the European Union. Before her role at Express Scripts, Gina was an attorney at Eli Lilly and Company, Inc. responsible for legal matters impacting the U.S. and global promotion of certain products.


American Health Lawyers Association (AHLA)